Search
Descriptor English: Calcifediol
Descriptor Spanish: Calcifediol
Descriptor calcifediol
Entry term(s) 25-hidroxicolecalciferol
25-hidroxivitamina D3
Scope note: Principal metabolito circulante de la vitamina D3 (COLECALCIFEROL). Se produce en el HÍGADO y es el mejor indicador de los depósitos de vitamina D del organismo. Es eficaz en el tratamiento del RAQUITISMO y de la OSTEOMALACIA, tanto en pacientes azotémicos como en los que no padecen esta alteración. El calcifediol también tiene propiedades mineralizantes.
Descriptor Portuguese: Calcifediol
Descriptor French: Calcifédiol
Entry term(s): 25 Hydroxycholecalciferol
25 Hydroxycholecalciferol Monohydrate
25 Hydroxyvitamin D 3
25 Hydroxyvitamin D3
25-Hydroxycholecalciferol
25-Hydroxycholecalciferol Monohydrate
25-Hydroxyvitamin D 3
25-Hydroxyvitamin D3
Anhydrous, Calcifediol
Calcidiol
Calcifediol Anhydrous
Calcifediol, (3 alpha,5Z,7E)-Isomer
Calcifediol, (3 beta,5E,7E)-Isomer
Calderol
Dedrogyl
Hidroferol
Monohydrate, 25-Hydroxycholecalciferol
Tree number(s): D04.210.500.247.222.159.478.250
D04.210.500.247.808.146.478.250
D04.210.500.812.768.196.478.250
D10.570.938.146.478.250
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D002112
Scope note: The major circulating metabolite of VITAMIN D3. It is produced in the LIVER and is the best indicator of the body's vitamin D stores. It is effective in the treatment of RICKETS and OSTEOMALACIA, both in azotemic and non-azotemic patients. Calcifediol also has mineralizing properties.
Annotation: deficiency: coordinate CALCIFEDIOL /defic (IM) with VITAMIN D DEFICIENCY (IM)
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BI biosynthesis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
DF deficiency
EC economics
GE genetics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PH physiology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Vitamins
Bone Density Conservation Agents
Registry Number: P6YZ13C99Q
CAS Type 1 Name: 9,10-Secocholesta-5,7,10(19)-triene-3,25-diol, (3beta,5Z,7E)-
Previous Indexing: Cholecalciferols (1966-1972)
Hydroxycholecalciferols (1972-1982)
Public MeSH Note: 83
History Note: 83
DeCS ID: 2146
Unique ID: D002112
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1983/01/01
Date of Entry: 1982/05/04
Revision Date: 2017/05/24
Calcifediol - Preferred
Concept UI M0003141
Scope note The major circulating metabolite of VITAMIN D3. It is produced in the LIVER and is the best indicator of the body's vitamin D stores. It is effective in the treatment of RICKETS and OSTEOMALACIA, both in azotemic and non-azotemic patients. Calcifediol also has mineralizing properties.
Preferred term Calcifediol
Entry term(s) 25 Hydroxycholecalciferol
25 Hydroxycholecalciferol Monohydrate
25 Hydroxyvitamin D 3
25 Hydroxyvitamin D3
25-Hydroxycholecalciferol
25-Hydroxycholecalciferol Monohydrate
25-Hydroxyvitamin D 3
25-Hydroxyvitamin D3
Calcidiol
Monohydrate, 25-Hydroxycholecalciferol
Calcifediol, (3 beta,5E,7E)-Isomer - Narrower
Concept UI M0330893
Preferred term Calcifediol, (3 beta,5E,7E)-Isomer
Calcifediol Anhydrous - Narrower
Concept UI M0585635
Preferred term Calcifediol Anhydrous
Entry term(s) Anhydrous, Calcifediol
Dedrogyl - Narrower
Concept UI M0462847
Preferred term Dedrogyl
Hidroferol - Narrower
Concept UI M0466590
Preferred term Hidroferol
Calcifediol, (3 alpha,5Z,7E)-Isomer - Narrower
Concept UI M0330894
Preferred term Calcifediol, (3 alpha,5Z,7E)-Isomer
Calderol - Narrower
Concept UI M0462848
Preferred term Calderol



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey